1) Stent type, crossing technique, and patient factors influence stent patency after CTO PCI. Drug-eluting stents are superior to bare metal stents in reducing restenosis and reocclusion. 2) Techniques involving extensive subintimal dissection and re-entry are associated with higher restenosis rates, especially if outflow and final TIMI flow are poor. 3) Patient factors like diabetes are also important determinants of stent patency, with diabetics having higher restenosis risks. 4) The role of routine angiographic follow-up after CTO PCI remains controversial.